 2014 Highlights
• Signing of two further OEM agreements. One with Gilson
Inc. for our single quadruple unit (the 4000 MiD
®
) and a
second with a leading global scientific company for our
triple quadrupole mass spectrometry technology
• Signing of an important agreement with Plexus Corp. for
the manufacture of the 4000 MiD
®
to meet increasing
demand
Post-period update
• Signing of an OEM agreement with GE Healthcare for
both the 4000 MiD
®
and our MiDas™ unit 
• Signing of a distributor agreement with Kinesis Ltd for the
distribution of our 4000 MiD
®
in the UK, Europe and India
Financial summary
• Revenue up 32% to £1.20 million (2013: £0.91 million)
• Placing of 10,500,000 ordinary shares raising
£4.41 million before costs
• Cash at 31 December 2014 £4.55 million
(2013: £3.24 million)
Microsaic Systems plc Annual Report and Financial Statements 2014 1
Highlights
Microsaic_pp01_07  26/03/2015  15:49  Page 1
